Rank | Gene Set | Z-score |
---|---|---|
1 | DNA deamination (GO:0045006) | 6.94248105 |
2 | viral transcription (GO:0019083) | 5.87062909 |
3 | translational termination (GO:0006415) | 5.67263235 |
4 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.61112541 |
5 | cotranslational protein targeting to membrane (GO:0006613) | 5.54977879 |
6 | protein targeting to ER (GO:0045047) | 5.52317047 |
7 | protein localization to endoplasmic reticulum (GO:0070972) | 5.38809331 |
8 | ribosomal small subunit assembly (GO:0000028) | 5.31108175 |
9 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.27519201 |
10 | ribosomal small subunit biogenesis (GO:0042274) | 5.03125333 |
11 | translational elongation (GO:0006414) | 4.81362573 |
12 | viral life cycle (GO:0019058) | 4.42825641 |
13 | signal peptide processing (GO:0006465) | 4.23123218 |
14 | translational initiation (GO:0006413) | 4.20881543 |
15 | cellular protein complex disassembly (GO:0043624) | 4.20461690 |
16 | proteasome assembly (GO:0043248) | 4.18931553 |
17 | ribosomal large subunit biogenesis (GO:0042273) | 4.17450661 |
18 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.02373090 |
19 | translation (GO:0006412) | 3.88520601 |
20 | protein targeting to membrane (GO:0006612) | 3.80195950 |
21 | chaperone-mediated protein transport (GO:0072321) | 3.73745928 |
22 | maturation of SSU-rRNA (GO:0030490) | 3.66017988 |
23 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.65725018 |
24 | GDP-mannose metabolic process (GO:0019673) | 3.62805079 |
25 | iron-sulfur cluster assembly (GO:0016226) | 3.59921367 |
26 | metallo-sulfur cluster assembly (GO:0031163) | 3.59921367 |
27 | regulation of cilium movement (GO:0003352) | 3.55890883 |
28 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.55793246 |
29 | protein complex disassembly (GO:0043241) | 3.54007499 |
30 | neutrophil activation involved in immune response (GO:0002283) | 3.52913114 |
31 | response to interferon-beta (GO:0035456) | 3.46056188 |
32 | axonemal dynein complex assembly (GO:0070286) | 3.44047783 |
33 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.39103541 |
34 | L-phenylalanine metabolic process (GO:0006558) | 3.36916185 |
35 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.36916185 |
36 | macromolecular complex disassembly (GO:0032984) | 3.36012946 |
37 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.34292185 |
38 | termination of RNA polymerase III transcription (GO:0006386) | 3.34292185 |
39 | L-methionine salvage (GO:0071267) | 3.32733599 |
40 | L-methionine biosynthetic process (GO:0071265) | 3.32733599 |
41 | amino acid salvage (GO:0043102) | 3.32733599 |
42 | kynurenine metabolic process (GO:0070189) | 3.31331330 |
43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.29953527 |
44 | GMP metabolic process (GO:0046037) | 3.29539074 |
45 | respiratory chain complex IV assembly (GO:0008535) | 3.27405902 |
46 | L-serine metabolic process (GO:0006563) | 3.26422345 |
47 | mannosylation (GO:0097502) | 3.19354287 |
48 | macrophage differentiation (GO:0030225) | 3.18698587 |
49 | regulation of mitochondrial translation (GO:0070129) | 3.10703857 |
50 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.04616418 |
51 | L-phenylalanine catabolic process (GO:0006559) | 3.04616418 |
52 | tryptophan catabolic process (GO:0006569) | 3.01849423 |
53 | indole-containing compound catabolic process (GO:0042436) | 3.01849423 |
54 | indolalkylamine catabolic process (GO:0046218) | 3.01849423 |
55 | response to xenobiotic stimulus (GO:0009410) | 3.01475297 |
56 | pseudouridine synthesis (GO:0001522) | 3.00175489 |
57 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.99748914 |
58 | central nervous system myelination (GO:0022010) | 2.99591836 |
59 | axon ensheathment in central nervous system (GO:0032291) | 2.99591836 |
60 | protein targeting to mitochondrion (GO:0006626) | 2.99145831 |
61 | heme biosynthetic process (GO:0006783) | 2.98502852 |
62 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.97845559 |
63 | serine family amino acid biosynthetic process (GO:0009070) | 2.92066647 |
64 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.88991919 |
65 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.87545032 |
66 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.86818264 |
67 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.86653248 |
68 | epithelial cilium movement (GO:0003351) | 2.85254673 |
69 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.84836859 |
70 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.84293660 |
71 | protein targeting (GO:0006605) | 2.82466168 |
72 | establishment of protein localization to mitochondrion (GO:0072655) | 2.81456253 |
73 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.80978324 |
74 | protein import into peroxisome matrix (GO:0016558) | 2.78271009 |
75 | folic acid transport (GO:0015884) | 2.77585047 |
76 | response to peptidoglycan (GO:0032494) | 2.77343977 |
77 | establishment of protein localization to membrane (GO:0090150) | 2.75908307 |
78 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.75655937 |
79 | cellular copper ion homeostasis (GO:0006878) | 2.75279190 |
80 | positive regulation of tolerance induction (GO:0002645) | 2.74886826 |
81 | oligosaccharide catabolic process (GO:0009313) | 2.74528921 |
82 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.74189343 |
83 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.73357194 |
84 | C-terminal protein lipidation (GO:0006501) | 2.73330562 |
85 | cilium movement (GO:0003341) | 2.73287544 |
86 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.73075039 |
87 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.73075039 |
88 | ATP synthesis coupled proton transport (GO:0015986) | 2.71799531 |
89 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.71799531 |
90 | folic acid metabolic process (GO:0046655) | 2.71558991 |
91 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.71312511 |
92 | cellular component biogenesis (GO:0044085) | 2.71287865 |
93 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.71201934 |
94 | cellular response to type I interferon (GO:0071357) | 2.69878982 |
95 | type I interferon signaling pathway (GO:0060337) | 2.69878982 |
96 | amyloid precursor protein catabolic process (GO:0042987) | 2.69840642 |
97 | mRNA catabolic process (GO:0006402) | 2.69769340 |
98 | copper ion homeostasis (GO:0055070) | 2.69669867 |
99 | nucleotide transmembrane transport (GO:1901679) | 2.69040175 |
100 | cellular metabolic compound salvage (GO:0043094) | 2.68649310 |
101 | GTP biosynthetic process (GO:0006183) | 2.68438887 |
102 | modulation by virus of host process (GO:0019054) | 2.67984678 |
103 | cytochrome complex assembly (GO:0017004) | 2.67128944 |
104 | protein deneddylation (GO:0000338) | 2.66535504 |
105 | regulation of podosome assembly (GO:0071801) | 2.66040060 |
106 | neutrophil activation (GO:0042119) | 2.65174461 |
107 | regulation of interferon-alpha production (GO:0032647) | 2.64588928 |
108 | cellular response to arsenic-containing substance (GO:0071243) | 2.63371070 |
109 | response to type I interferon (GO:0034340) | 2.62445718 |
110 | amino sugar catabolic process (GO:0046348) | 2.62094335 |
111 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.60966670 |
112 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.60656216 |
113 | negative regulation of ligase activity (GO:0051352) | 2.60656216 |
114 | autophagic vacuole fusion (GO:0000046) | 2.60518519 |
115 | glycine metabolic process (GO:0006544) | 2.59440758 |
116 | CTP metabolic process (GO:0046036) | 2.59322570 |
117 | CTP biosynthetic process (GO:0006241) | 2.59322570 |
118 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.58234335 |
119 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.56128653 |
120 | regulation of RIG-I signaling pathway (GO:0039535) | 2.55579833 |
121 | protein complex biogenesis (GO:0070271) | 2.55259209 |
122 | heme metabolic process (GO:0042168) | 2.54990948 |
123 | protein localization to mitochondrion (GO:0070585) | 2.54315463 |
124 | establishment of protein localization to organelle (GO:0072594) | 2.54047050 |
125 | deoxyribonucleotide catabolic process (GO:0009264) | 2.53449148 |
126 | GPI anchor biosynthetic process (GO:0006506) | 2.51822129 |
127 | protein maturation by protein folding (GO:0022417) | 2.51208742 |
128 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.51198506 |
129 | regulation of tolerance induction (GO:0002643) | 2.50969657 |
130 | RNA catabolic process (GO:0006401) | 2.50963784 |
131 | granulocyte activation (GO:0036230) | 2.50784464 |
132 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.49863163 |
133 | cellular response to zinc ion (GO:0071294) | 2.49064588 |
134 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.48839489 |
135 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.47558092 |
136 | amyloid precursor protein metabolic process (GO:0042982) | 2.47268198 |
137 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.47212533 |
138 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.47179789 |
139 | rRNA processing (GO:0006364) | 2.45808625 |
140 | respiratory electron transport chain (GO:0022904) | 2.45685505 |
141 | protein retention in ER lumen (GO:0006621) | 2.44865810 |
142 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.44573362 |
143 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.44482975 |
144 | tryptophan metabolic process (GO:0006568) | 2.44101673 |
145 | regulation of chemokine biosynthetic process (GO:0045073) | 2.43236452 |
146 | protein targeting to peroxisome (GO:0006625) | 2.41877249 |
147 | establishment of protein localization to peroxisome (GO:0072663) | 2.41877249 |
148 | protein localization to peroxisome (GO:0072662) | 2.41877249 |
149 | negative regulation of viral entry into host cell (GO:0046597) | 2.41531107 |
150 | peroxisomal transport (GO:0043574) | 2.41418980 |
151 | regulation of metalloenzyme activity (GO:0048552) | 2.41385292 |
152 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.40913845 |
153 | copper ion transport (GO:0006825) | 2.40550175 |
154 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.40540963 |
155 | positive regulation of interferon-alpha production (GO:0032727) | 2.39657643 |
156 | positive regulation of interferon-beta production (GO:0032728) | 2.39587455 |
157 | mitochondrion degradation (GO:0000422) | 2.38848261 |
158 | negative regulation of chemokine production (GO:0032682) | 2.37348144 |
159 | cellular biogenic amine catabolic process (GO:0042402) | 2.37214815 |
160 | amine catabolic process (GO:0009310) | 2.37214815 |
161 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.36969241 |
162 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.36969241 |
163 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.36895927 |
164 | cullin deneddylation (GO:0010388) | 2.36751013 |
165 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.36636211 |
166 | base-excision repair, AP site formation (GO:0006285) | 2.35922213 |
167 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.34744818 |
168 | transcription from mitochondrial promoter (GO:0006390) | 2.34578580 |
169 | membrane lipid catabolic process (GO:0046466) | 2.33560208 |
170 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.33538634 |
171 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.33538634 |
172 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.33538634 |
173 | C-terminal protein amino acid modification (GO:0018410) | 2.33488926 |
174 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.32178230 |
175 | sphingolipid catabolic process (GO:0030149) | 2.31612159 |
176 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.31149561 |
177 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.30338365 |
178 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.30294970 |
179 | glycosphingolipid catabolic process (GO:0046479) | 2.30068690 |
180 | regulation of T cell tolerance induction (GO:0002664) | 2.30019253 |
181 | negative regulation of protein autophosphorylation (GO:0031953) | 2.29069823 |
182 | positive regulation of protein homooligomerization (GO:0032464) | 2.28639528 |
183 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.27474189 |
184 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.26973704 |
185 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.26702755 |
186 | negative regulation of cell killing (GO:0031342) | 2.26171074 |
187 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.26171074 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.92252248 |
2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.61005580 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.42211196 |
4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.40315281 |
5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.37525323 |
6 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.04819774 |
7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.99807297 |
8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.93678420 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.79522410 |
10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.75557445 |
11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.60733321 |
12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.54948649 |
13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.46902700 |
14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.46693476 |
15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.27678805 |
16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.27421033 |
17 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.25477213 |
18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.18147801 |
19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.14541016 |
20 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13857449 |
21 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11266968 |
22 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.10713804 |
23 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.08408806 |
24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.06785379 |
25 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.03274241 |
26 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.00809986 |
27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.00363660 |
28 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.98628752 |
29 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.96117364 |
30 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.95512909 |
31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.93953351 |
32 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.92718592 |
33 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.85654102 |
34 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85461295 |
35 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.83667326 |
36 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.79515641 |
37 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.78499326 |
38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.78076276 |
39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.76854558 |
40 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.76679158 |
41 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.73222670 |
42 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71962112 |
43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71107165 |
44 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.70218818 |
45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.67993879 |
46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64365231 |
47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.60987110 |
48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.60217136 |
49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.57503086 |
50 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.54333635 |
51 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.51457573 |
52 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51214338 |
53 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46716928 |
54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.46137086 |
55 | * ELF5_23300383_ChIP-Seq_T47D_Human | 1.45043998 |
56 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.43549693 |
57 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43531017 |
58 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43465094 |
59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.42454499 |
60 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.41989863 |
61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41620366 |
62 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.41112330 |
63 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.40734191 |
64 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39072337 |
65 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38464029 |
66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38248430 |
67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.37799562 |
68 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.37614936 |
69 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.36240563 |
70 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.33388980 |
71 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33194406 |
72 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33087710 |
73 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31129479 |
74 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.29381897 |
75 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28966818 |
76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.28084957 |
77 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.26876945 |
78 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.26194594 |
79 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24580790 |
80 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24122401 |
81 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.23862451 |
82 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.23162916 |
83 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.22920581 |
84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22768136 |
85 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21959752 |
86 | GATA3_26560356_Chip-Seq_TH2_Human | 1.21293413 |
87 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.21046622 |
88 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.20938717 |
89 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20866997 |
90 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19579168 |
91 | MAF_26560356_Chip-Seq_TH2_Human | 1.19477828 |
92 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.19050211 |
93 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.18476820 |
94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13974369 |
95 | MYC_22102868_ChIP-Seq_BL_Human | 1.12664054 |
96 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12630700 |
97 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12493943 |
98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12314322 |
99 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.12253294 |
100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12029765 |
101 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11045934 |
102 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.08627027 |
103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08426383 |
104 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08124422 |
105 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.07417364 |
106 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07266938 |
107 | AR_20517297_ChIP-Seq_VCAP_Human | 1.07147801 |
108 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06791817 |
109 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.06574680 |
110 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06353233 |
111 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05901461 |
112 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05152212 |
113 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.05058945 |
114 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.04721388 |
115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04349188 |
116 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.04259416 |
117 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.04088809 |
118 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.03952865 |
119 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.03680951 |
120 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.03090392 |
121 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03071734 |
122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02687243 |
123 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02611307 |
124 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02209876 |
125 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01821497 |
126 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01487060 |
127 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01332474 |
128 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01081803 |
129 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01075028 |
130 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99672040 |
131 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99313245 |
132 | MAF_26560356_Chip-Seq_TH1_Human | 0.99123565 |
133 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98961102 |
134 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.98204133 |
135 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97767739 |
136 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.94046696 |
137 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92223741 |
138 | MYB_26560356_Chip-Seq_TH2_Human | 0.92179014 |
139 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90730651 |
140 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89347664 |
141 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.87904864 |
142 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86831237 |
143 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85046476 |
144 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.84591157 |
145 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84499423 |
146 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84172221 |
147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83150804 |
148 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81226030 |
149 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.80799911 |
150 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78825689 |
151 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.76037929 |
152 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75303985 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009840_abnormal_foam_cell | 5.13364895 |
2 | MP0002139_abnormal_hepatobiliary_system | 2.88999169 |
3 | MP0003806_abnormal_nucleotide_metabolis | 2.62221878 |
4 | MP0000685_abnormal_immune_system | 2.62012957 |
5 | MP0005083_abnormal_biliary_tract | 2.46206218 |
6 | MP0005365_abnormal_bile_salt | 2.45746562 |
7 | MP0003195_calcinosis | 2.37566984 |
8 | MP0001666_abnormal_nutrient_absorption | 2.31202643 |
9 | MP0003011_delayed_dark_adaptation | 2.23504810 |
10 | MP0003186_abnormal_redox_activity | 2.17751962 |
11 | MP0005058_abnormal_lysosome_morphology | 2.14878185 |
12 | MP0005671_abnormal_response_to | 2.12397849 |
13 | MP0009379_abnormal_foot_pigmentation | 2.06240966 |
14 | MP0003252_abnormal_bile_duct | 2.04140658 |
15 | MP0009333_abnormal_splenocyte_physiolog | 2.00636154 |
16 | MP0004381_abnormal_hair_follicle | 1.99872301 |
17 | MP0008260_abnormal_autophagy | 1.97476376 |
18 | MP0003693_abnormal_embryo_hatching | 1.95666441 |
19 | MP0003724_increased_susceptibility_to | 1.90254191 |
20 | MP0003866_abnormal_defecation | 1.89675792 |
21 | MP0003656_abnormal_erythrocyte_physiolo | 1.89497269 |
22 | MP0009785_altered_susceptibility_to | 1.89098641 |
23 | MP0005360_urolithiasis | 1.83492018 |
24 | MP0005332_abnormal_amino_acid | 1.82001789 |
25 | MP0001764_abnormal_homeostasis | 1.81382560 |
26 | MP0002132_abnormal_respiratory_system | 1.78834021 |
27 | MP0006054_spinal_hemorrhage | 1.77560242 |
28 | MP0005387_immune_system_phenotype | 1.74868850 |
29 | MP0001790_abnormal_immune_system | 1.74868850 |
30 | MP0001835_abnormal_antigen_presentation | 1.72881351 |
31 | MP0005220_abnormal_exocrine_pancreas | 1.70280058 |
32 | MP0006036_abnormal_mitochondrial_physio | 1.70224018 |
33 | MP0001533_abnormal_skeleton_physiology | 1.69675736 |
34 | MP0009764_decreased_sensitivity_to | 1.68936285 |
35 | MP0005085_abnormal_gallbladder_physiolo | 1.68550748 |
36 | MP0005025_abnormal_response_to | 1.64081569 |
37 | MP0005451_abnormal_body_composition | 1.60256722 |
38 | MP0005084_abnormal_gallbladder_morpholo | 1.59921820 |
39 | MP0002723_abnormal_immune_serum | 1.59040245 |
40 | MP0003763_abnormal_thymus_physiology | 1.58092219 |
41 | MP0003191_abnormal_cellular_cholesterol | 1.54247920 |
42 | MP0001800_abnormal_humoral_immune | 1.54072925 |
43 | MP0010234_abnormal_vibrissa_follicle | 1.49871958 |
44 | MP0004264_abnormal_extraembryonic_tissu | 1.47859456 |
45 | MP0005000_abnormal_immune_tolerance | 1.47518975 |
46 | MP0000920_abnormal_myelination | 1.47129723 |
47 | MP0003868_abnormal_feces_composition | 1.46955224 |
48 | MP0002277_abnormal_respiratory_mucosa | 1.46383796 |
49 | MP0000343_altered_response_to | 1.45917209 |
50 | MP0008875_abnormal_xenobiotic_pharmacok | 1.45017613 |
51 | MP0000490_abnormal_crypts_of | 1.43712137 |
52 | MP0002420_abnormal_adaptive_immunity | 1.42951268 |
53 | MP0010386_abnormal_urinary_bladder | 1.42585680 |
54 | MP0002332_abnormal_exercise_endurance | 1.40140145 |
55 | MP0001819_abnormal_immune_cell | 1.39605211 |
56 | MP0001873_stomach_inflammation | 1.39126722 |
57 | MP0008469_abnormal_protein_level | 1.39044582 |
58 | MP0009115_abnormal_fat_cell | 1.37942883 |
59 | MP0005075_abnormal_melanosome_morpholog | 1.37736307 |
60 | MP0002452_abnormal_antigen_presenting | 1.37506123 |
61 | MP0009643_abnormal_urine_homeostasis | 1.37336763 |
62 | MP0002254_reproductive_system_inflammat | 1.35972471 |
63 | MP0005636_abnormal_mineral_homeostasis | 1.35454948 |
64 | MP0003300_gastrointestinal_ulcer | 1.34922784 |
65 | MP0004043_abnormal_pH_regulation | 1.34211656 |
66 | MP0006082_CNS_inflammation | 1.33945912 |
67 | MP0001727_abnormal_embryo_implantation | 1.32412074 |
68 | MP0003786_premature_aging | 1.29619322 |
69 | MP0000716_abnormal_immune_system | 1.29399762 |
70 | MP0001853_heart_inflammation | 1.29156271 |
71 | MP0003075_altered_response_to | 1.29102272 |
72 | MP0002398_abnormal_bone_marrow | 1.28791370 |
73 | MP0000689_abnormal_spleen_morphology | 1.28663833 |
74 | MP0002693_abnormal_pancreas_physiology | 1.26843603 |
75 | MP0000465_gastrointestinal_hemorrhage | 1.26646628 |
76 | MP0005164_abnormal_response_to | 1.25397364 |
77 | MP0003436_decreased_susceptibility_to | 1.22826625 |
78 | MP0000609_abnormal_liver_physiology | 1.21946507 |
79 | MP0002419_abnormal_innate_immunity | 1.21894554 |
80 | MP0002429_abnormal_blood_cell | 1.21205523 |
81 | MP0002928_abnormal_bile_duct | 1.20271775 |
82 | MP0003303_peritoneal_inflammation | 1.16842872 |
83 | MP0003172_abnormal_lysosome_physiology | 1.16760946 |
84 | MP0003136_yellow_coat_color | 1.16644723 |
85 | MP0005310_abnormal_salivary_gland | 1.16248502 |
86 | MP0002722_abnormal_immune_system | 1.16220230 |
87 | MP0002118_abnormal_lipid_homeostasis | 1.15456887 |
88 | MP0000858_altered_metastatic_potential | 1.14891457 |
89 | MP0004957_abnormal_blastocyst_morpholog | 1.14783719 |
90 | MP0002148_abnormal_hypersensitivity_rea | 1.14139598 |
91 | MP0001845_abnormal_inflammatory_respons | 1.14019541 |
92 | MP0005464_abnormal_platelet_physiology | 1.13020927 |
93 | MP0003329_amyloid_beta_deposits | 1.10631364 |
94 | MP0003718_maternal_effect | 1.10469312 |
95 | MP0004019_abnormal_vitamin_homeostasis | 1.10119665 |
96 | MP0002405_respiratory_system_inflammati | 1.09862339 |
97 | MP0010155_abnormal_intestine_physiology | 1.09209402 |
98 | MP0000613_abnormal_salivary_gland | 1.07965245 |
99 | MP0001944_abnormal_pancreas_morphology | 1.06811425 |
100 | MP0000372_irregular_coat_pigmentation | 1.06688576 |
101 | MP0002653_abnormal_ependyma_morphology | 1.05601383 |
102 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05012113 |
103 | MP0001663_abnormal_digestive_system | 1.01502409 |
104 | MP0004133_heterotaxia | 1.01083534 |
105 | MP0002638_abnormal_pupillary_reflex | 1.00771201 |
106 | MP0001851_eye_inflammation | 0.99409058 |
107 | MP0010678_abnormal_skin_adnexa | 0.98606647 |
108 | MP0005381_digestive/alimentary_phenotyp | 0.98011867 |
109 | MP0008873_increased_physiological_sensi | 0.97914004 |
110 | MP0001661_extended_life_span | 0.94433527 |
111 | MP0005376_homeostasis/metabolism_phenot | 0.93044204 |
112 | MP0004142_abnormal_muscle_tone | 0.92164760 |
113 | MP0000427_abnormal_hair_cycle | 0.90255165 |
114 | MP0005408_hypopigmentation | 0.86888866 |
115 | MP0002396_abnormal_hematopoietic_system | 0.86775655 |
116 | MP0005165_increased_susceptibility_to | 0.86646486 |
117 | MP0002933_joint_inflammation | 0.85970620 |
118 | MP0002138_abnormal_hepatobiliary_system | 0.84917965 |
119 | MP0005319_abnormal_enzyme/_coenzyme | 0.84544905 |
120 | MP0009765_abnormal_xenobiotic_induced | 0.84269170 |
121 | MP0001905_abnormal_dopamine_level | 0.83870154 |
122 | MP0009642_abnormal_blood_homeostasis | 0.82811002 |
123 | MP0000703_abnormal_thymus_morphology | 0.81532659 |
124 | MP0004147_increased_porphyrin_level | 0.80703946 |
125 | MP0010329_abnormal_lipoprotein_level | 0.79944275 |
126 | MP0006035_abnormal_mitochondrial_morpho | 0.79723334 |
127 | MP0005379_endocrine/exocrine_gland_phen | 0.79465028 |
128 | MP0004947_skin_inflammation | 0.79253477 |
129 | MP0000358_abnormal_cell_content/ | 0.77435119 |
130 | MP0000598_abnormal_liver_morphology | 0.77274125 |
131 | MP0001756_abnormal_urination | 0.76934857 |
132 | MP0006072_abnormal_retinal_apoptosis | 0.76925249 |
133 | MP0000604_amyloidosis | 0.76877936 |
134 | MP0005023_abnormal_wound_healing | 0.75439232 |
135 | MP0002136_abnormal_kidney_physiology | 0.74712475 |
136 | MP0009763_increased_sensitivity_to | 0.74446337 |
137 | MP0001324_abnormal_eye_pigmentation | 0.73038704 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.42985350 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.29661489 |
3 | Abnormal number of erythroid precursors (HP:0012131) | 4.24047484 |
4 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.92788894 |
5 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.92788894 |
6 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.72981288 |
7 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.65193765 |
8 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.65193765 |
9 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.64992147 |
10 | Absent/shortened dynein arms (HP:0200106) | 3.64992147 |
11 | Macrocytic anemia (HP:0001972) | 3.64794876 |
12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.63373679 |
13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.63373679 |
14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.63373679 |
15 | Hepatocellular necrosis (HP:0001404) | 3.53164911 |
16 | Rhinitis (HP:0012384) | 3.50129797 |
17 | Hepatic necrosis (HP:0002605) | 3.45147685 |
18 | Abnormal ciliary motility (HP:0012262) | 3.44950010 |
19 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.44849614 |
20 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.36771851 |
21 | Cerebral hypomyelination (HP:0006808) | 3.27105903 |
22 | 3-Methylglutaconic aciduria (HP:0003535) | 3.22901247 |
23 | Orchitis (HP:0100796) | 3.14094324 |
24 | Retrobulbar optic neuritis (HP:0100654) | 3.04662720 |
25 | Optic neuritis (HP:0100653) | 3.04662720 |
26 | Loss of speech (HP:0002371) | 3.02250184 |
27 | Reticulocytopenia (HP:0001896) | 2.99976861 |
28 | Mitochondrial inheritance (HP:0001427) | 2.99217183 |
29 | Vacuolated lymphocytes (HP:0001922) | 2.96917390 |
30 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.89974972 |
31 | Spastic paraparesis (HP:0002313) | 2.79558495 |
32 | Myositis (HP:0100614) | 2.76715709 |
33 | Pallor (HP:0000980) | 2.76327505 |
34 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.75095486 |
35 | Split foot (HP:0001839) | 2.74130383 |
36 | Stomatitis (HP:0010280) | 2.73933251 |
37 | Increased IgM level (HP:0003496) | 2.72830093 |
38 | Increased cerebral lipofuscin (HP:0011813) | 2.71211997 |
39 | Acute necrotizing encephalopathy (HP:0006965) | 2.70834031 |
40 | Progressive muscle weakness (HP:0003323) | 2.70768764 |
41 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.70537053 |
42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.67919159 |
43 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.65522057 |
44 | Tetraparesis (HP:0002273) | 2.64077156 |
45 | Chronic otitis media (HP:0000389) | 2.62681471 |
46 | Brushfield spots (HP:0001088) | 2.61902459 |
47 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.61684591 |
48 | Recurrent abscess formation (HP:0002722) | 2.59047330 |
49 | Acute encephalopathy (HP:0006846) | 2.58433231 |
50 | Recurrent bacterial skin infections (HP:0005406) | 2.56565920 |
51 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.56558529 |
52 | Agnosia (HP:0010524) | 2.56474312 |
53 | Hypoplasia of the uterus (HP:0000013) | 2.56465807 |
54 | Nasal polyposis (HP:0100582) | 2.54231191 |
55 | Type I transferrin isoform profile (HP:0003642) | 2.53941671 |
56 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.52344962 |
57 | Increased CSF lactate (HP:0002490) | 2.49758052 |
58 | Increased intramyocellular lipid droplets (HP:0012240) | 2.48134179 |
59 | Aplastic anemia (HP:0001915) | 2.45907518 |
60 | Petechiae (HP:0000967) | 2.45743489 |
61 | Increased serum lactate (HP:0002151) | 2.45073141 |
62 | Poor head control (HP:0002421) | 2.44393768 |
63 | Systemic lupus erythematosus (HP:0002725) | 2.42428318 |
64 | Xanthomatosis (HP:0000991) | 2.41901286 |
65 | Progressive neurologic deterioration (HP:0002344) | 2.37888907 |
66 | Disinhibition (HP:0000734) | 2.36732075 |
67 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.36428097 |
68 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.36428097 |
69 | Abnormal protein glycosylation (HP:0012346) | 2.36428097 |
70 | Abnormal glycosylation (HP:0012345) | 2.36428097 |
71 | Bronchiectasis (HP:0002110) | 2.35122487 |
72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.34633012 |
73 | Dicarboxylic aciduria (HP:0003215) | 2.34633012 |
74 | Prolonged neonatal jaundice (HP:0006579) | 2.34618194 |
75 | Axonal loss (HP:0003447) | 2.33871745 |
76 | Reduced antithrombin III activity (HP:0001976) | 2.33844471 |
77 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.32815705 |
78 | Increased muscle lipid content (HP:0009058) | 2.32407289 |
79 | Hyperlipoproteinemia (HP:0010980) | 2.31141421 |
80 | Lactic acidosis (HP:0003128) | 2.29265866 |
81 | Renal Fanconi syndrome (HP:0001994) | 2.27600320 |
82 | Abnormality of macrophages (HP:0004311) | 2.26767888 |
83 | Generalized aminoaciduria (HP:0002909) | 2.25880963 |
84 | Abnormality of T cell physiology (HP:0011840) | 2.25733694 |
85 | Hyperglycinemia (HP:0002154) | 2.25442115 |
86 | IgM deficiency (HP:0002850) | 2.23885843 |
87 | CNS hypomyelination (HP:0003429) | 2.23338092 |
88 | Increased hepatocellular lipid droplets (HP:0006565) | 2.23129194 |
89 | Eczematoid dermatitis (HP:0000976) | 2.22029051 |
90 | Lipid accumulation in hepatocytes (HP:0006561) | 2.19154588 |
91 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.19144529 |
92 | Lethargy (HP:0001254) | 2.16528030 |
93 | Megaloblastic anemia (HP:0001889) | 2.14515544 |
94 | Acute hepatic failure (HP:0006554) | 2.13892135 |
95 | Microretrognathia (HP:0000308) | 2.13764533 |
96 | CNS demyelination (HP:0007305) | 2.12610842 |
97 | Secondary amenorrhea (HP:0000869) | 2.11855920 |
98 | Abnormality of the nasal mucosa (HP:0000433) | 2.11247337 |
99 | Respiratory failure (HP:0002878) | 2.10112654 |
100 | Increased serum ferritin (HP:0003281) | 2.09803195 |
101 | Polyneuropathy (HP:0001271) | 2.09557672 |
102 | Purpura (HP:0000979) | 2.09391851 |
103 | Chronic sinusitis (HP:0011109) | 2.08952890 |
104 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.08896867 |
105 | Upper motor neuron abnormality (HP:0002127) | 2.08882606 |
106 | Cerebral edema (HP:0002181) | 2.07781075 |
107 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.07491587 |
108 | Anorexia (HP:0002039) | 2.04278196 |
109 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.02904115 |
110 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.02350195 |
111 | Chronic bronchitis (HP:0004469) | 2.00988067 |
112 | Medial flaring of the eyebrow (HP:0010747) | 2.00665561 |
113 | Methylmalonic aciduria (HP:0012120) | 1.96960640 |
114 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.95295583 |
115 | Abnormality of glycine metabolism (HP:0010895) | 1.95295583 |
116 | Paraparesis (HP:0002385) | 1.94766583 |
117 | Nuclear cataract (HP:0100018) | 1.94255674 |
118 | Tubulointerstitial nephritis (HP:0001970) | 1.93929983 |
119 | Hypoglycemic coma (HP:0001325) | 1.93767235 |
120 | Personality changes (HP:0000751) | 1.93543948 |
121 | Neurofibrillary tangles (HP:0002185) | 1.93183593 |
122 | Progressive macrocephaly (HP:0004481) | 1.92241925 |
123 | Abnormality of serum amino acid levels (HP:0003112) | 1.92183735 |
124 | Tubulointerstitial fibrosis (HP:0005576) | 1.90953997 |
125 | Dysostosis multiplex (HP:0000943) | 1.90578766 |
126 | Pancytopenia (HP:0001876) | 1.90371269 |
127 | Opisthotonus (HP:0002179) | 1.89166093 |
128 | Tubulointerstitial abnormality (HP:0001969) | 1.88039415 |
129 | Pulmonary infiltrates (HP:0002113) | 1.87243619 |
130 | Panhypogammaglobulinemia (HP:0003139) | 1.86534341 |
131 | IgG deficiency (HP:0004315) | 1.86084365 |
132 | Hypokinesia (HP:0002375) | 1.85874078 |
133 | Hyperphosphaturia (HP:0003109) | 1.84139547 |
134 | Amyloidosis (HP:0011034) | 1.83951222 |
135 | Prolonged partial thromboplastin time (HP:0003645) | 1.83741849 |
136 | Vascular calcification (HP:0004934) | 1.82933396 |
137 | Delayed CNS myelination (HP:0002188) | 1.82534460 |
138 | Glomerulonephritis (HP:0000099) | 1.81646014 |
139 | Exertional dyspnea (HP:0002875) | 1.79592148 |
140 | Abnormality of the pericardium (HP:0001697) | 1.79465218 |
141 | Adrenal hypoplasia (HP:0000835) | 1.78889820 |
142 | Leukodystrophy (HP:0002415) | 1.78596846 |
143 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.78040354 |
144 | Microcytic anemia (HP:0001935) | 1.77950719 |
145 | Entropion (HP:0000621) | 1.77751895 |
146 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77537159 |
147 | Male infertility (HP:0003251) | 1.77254616 |
148 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.77121084 |
149 | Premature ovarian failure (HP:0008209) | 1.76822577 |
150 | Rough bone trabeculation (HP:0100670) | 1.75807195 |
151 | Delusions (HP:0000746) | 1.75666216 |
152 | Abnormality of T cells (HP:0002843) | 1.75139655 |
153 | Emotional lability (HP:0000712) | 1.74756608 |
154 | Microvesicular hepatic steatosis (HP:0001414) | 1.74130331 |
155 | Intrahepatic cholestasis (HP:0001406) | 1.73782087 |
156 | Hepatosplenomegaly (HP:0001433) | 1.72759417 |
157 | Choroideremia (HP:0001139) | 1.71605700 |
158 | Hypoglycemic seizures (HP:0002173) | 1.71195271 |
159 | True hermaphroditism (HP:0010459) | 1.71183644 |
160 | Posterior subcapsular cataract (HP:0007787) | 1.70867733 |
161 | Gangrene (HP:0100758) | 1.70536221 |
162 | Keratoconjunctivitis (HP:0001096) | 1.69452282 |
163 | Congenital sensorineural hearing impairment (HP:0008527) | 1.69088972 |
164 | Congenital primary aphakia (HP:0007707) | 1.67210236 |
165 | Keratoconjunctivitis sicca (HP:0001097) | 1.66257329 |
166 | Recurrent skin infections (HP:0001581) | 1.63512542 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NME2 | 4.32227312 |
2 | BCKDK | 3.87717801 |
3 | TESK2 | 3.64017726 |
4 | STK16 | 3.41453535 |
5 | BUB1 | 3.23123461 |
6 | TLK1 | 3.21497256 |
7 | TRIM28 | 3.11419185 |
8 | MST4 | 2.89795874 |
9 | EIF2AK1 | 2.76079198 |
10 | MAP4K1 | 2.70795391 |
11 | PDK2 | 2.62664627 |
12 | SIK3 | 2.56651214 |
13 | CDK19 | 2.35457892 |
14 | DYRK3 | 2.27511811 |
15 | TGFBR2 | 2.12946542 |
16 | ERN1 | 2.11791341 |
17 | BLK | 2.06067501 |
18 | EIF2AK3 | 2.01117954 |
19 | MST1R | 1.99533288 |
20 | MAP4K2 | 1.92225837 |
21 | FRK | 1.84767141 |
22 | KDR | 1.84262435 |
23 | RIPK1 | 1.77733524 |
24 | IRAK4 | 1.77106151 |
25 | EPHB1 | 1.73725034 |
26 | MAP3K12 | 1.73233763 |
27 | MAP2K2 | 1.72979563 |
28 | IRAK3 | 1.72726999 |
29 | WEE1 | 1.72241244 |
30 | EPHA3 | 1.69412285 |
31 | PIM2 | 1.67092692 |
32 | VRK2 | 1.64535462 |
33 | ACVR1B | 1.63360765 |
34 | NME1 | 1.58883509 |
35 | MAP3K11 | 1.52389811 |
36 | NEK6 | 1.51120158 |
37 | STK10 | 1.45976267 |
38 | BMPR1B | 1.40884892 |
39 | MAPKAPK5 | 1.39135523 |
40 | GRK7 | 1.32913440 |
41 | ZAP70 | 1.32610558 |
42 | FLT3 | 1.31170108 |
43 | INSRR | 1.27550310 |
44 | TBK1 | 1.22981430 |
45 | MAPK15 | 1.21073847 |
46 | ERBB4 | 1.19648722 |
47 | PBK | 1.17356307 |
48 | SCYL2 | 1.15524257 |
49 | RPS6KA4 | 1.13568411 |
50 | BTK | 1.10752462 |
51 | MUSK | 1.10236654 |
52 | VRK1 | 1.10195419 |
53 | MAP3K3 | 1.08506708 |
54 | JAK1 | 1.08153553 |
55 | IRAK1 | 1.07864145 |
56 | ARAF | 1.07604715 |
57 | NLK | 1.06245971 |
58 | STK39 | 1.06124019 |
59 | BRAF | 1.04953070 |
60 | CDK8 | 1.01735300 |
61 | ERBB3 | 0.99229743 |
62 | TEC | 0.98447370 |
63 | MAP3K14 | 0.95775729 |
64 | DYRK2 | 0.94162491 |
65 | TXK | 0.93097943 |
66 | KIT | 0.93027178 |
67 | GRK6 | 0.92535527 |
68 | RPS6KA5 | 0.87750053 |
69 | CLK1 | 0.86568922 |
70 | TNIK | 0.86341870 |
71 | ABL2 | 0.83818455 |
72 | TYK2 | 0.83818358 |
73 | IKBKE | 0.81820492 |
74 | TIE1 | 0.78440497 |
75 | TAOK3 | 0.76226390 |
76 | IRAK2 | 0.75879540 |
77 | EPHA2 | 0.75754513 |
78 | PINK1 | 0.75603256 |
79 | MAPKAPK3 | 0.73816326 |
80 | SYK | 0.72083301 |
81 | MAP2K3 | 0.71713915 |
82 | PLK3 | 0.71578437 |
83 | DYRK1B | 0.70693130 |
84 | DAPK3 | 0.70623444 |
85 | YES1 | 0.70210786 |
86 | HIPK2 | 0.70037920 |
87 | IKBKB | 0.69604976 |
88 | GRK1 | 0.69059702 |
89 | CSF1R | 0.67017953 |
90 | LIMK1 | 0.66487433 |
91 | CHUK | 0.65870427 |
92 | MAP3K10 | 0.64992698 |
93 | ILK | 0.64567181 |
94 | LRRK2 | 0.63440803 |
95 | AURKA | 0.62304259 |
96 | LYN | 0.59864136 |
97 | BRSK2 | 0.59846172 |
98 | MAP3K2 | 0.58997468 |
99 | PRKD2 | 0.57270094 |
100 | PAK1 | 0.56135483 |
101 | FER | 0.55258562 |
102 | FES | 0.54858120 |
103 | FGFR4 | 0.54825767 |
104 | JAK3 | 0.53842822 |
105 | ADRBK1 | 0.53651910 |
106 | BCR | 0.53512251 |
107 | PIK3CG | 0.52802611 |
108 | LCK | 0.52119746 |
109 | TESK1 | 0.51184728 |
110 | CSNK1A1L | 0.51057929 |
111 | CSNK1G3 | 0.49991933 |
112 | WNK4 | 0.49774804 |
113 | SRPK1 | 0.48713378 |
114 | MKNK2 | 0.48367957 |
115 | NUAK1 | 0.46929479 |
116 | LMTK2 | 0.46099245 |
117 | CAMK2B | 0.45695899 |
118 | MAPK4 | 0.45664450 |
119 | MAPK12 | 0.44968661 |
120 | MAPK11 | 0.44657795 |
121 | CAMK2G | 0.44483100 |
122 | HCK | 0.44086979 |
123 | CAMKK2 | 0.43400241 |
124 | MAP3K1 | 0.42281025 |
125 | OXSR1 | 0.41941472 |
126 | PRKCE | 0.40683658 |
127 | PIK3CA | 0.40017882 |
128 | RAF1 | 0.39536326 |
129 | PRKCI | 0.39099525 |
130 | JAK2 | 0.38336001 |
131 | ABL1 | 0.37447153 |
132 | ADRBK2 | 0.37418253 |
133 | MAP2K6 | 0.36685297 |
134 | PRKG2 | 0.36470479 |
135 | TAOK1 | 0.36289494 |
136 | RPS6KB2 | 0.35605240 |
137 | PAK4 | 0.35588460 |
138 | MELK | 0.35131077 |
139 | MOS | 0.34980031 |
140 | MAP3K8 | 0.34910108 |
141 | MAP3K5 | 0.34249891 |
142 | TRPM7 | 0.33645089 |
143 | CSNK1G1 | 0.33487240 |
144 | PRKCD | 0.31719356 |
145 | CSK | 0.31525272 |
146 | MAPKAPK2 | 0.31196820 |
147 | PASK | 0.30725174 |
148 | PRKCQ | 0.30466900 |
149 | FGFR2 | 0.30310651 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 4.98867220 |
2 | Protein export_Homo sapiens_hsa03060 | 4.03132092 |
3 | Folate biosynthesis_Homo sapiens_hsa00790 | 3.42678054 |
4 | Proteasome_Homo sapiens_hsa03050 | 3.06816127 |
5 | RNA polymerase_Homo sapiens_hsa03020 | 2.57817197 |
6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.53213232 |
7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.30140216 |
8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.07715529 |
9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.97389134 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.95444032 |
11 | Parkinsons disease_Homo sapiens_hsa05012 | 1.90250345 |
12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.88843461 |
13 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.82551654 |
14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.72532128 |
15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.70823093 |
16 | DNA replication_Homo sapiens_hsa03030 | 1.70775474 |
17 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.69756649 |
18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.65027592 |
19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.62486594 |
20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.60425089 |
21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.56317330 |
22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.55768621 |
23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49805284 |
24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.46247173 |
25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.44817473 |
26 | Legionellosis_Homo sapiens_hsa05134 | 1.43648123 |
27 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.42453611 |
28 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.39718509 |
29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37231966 |
30 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.36762041 |
31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30683213 |
32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.30653462 |
33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.29230230 |
34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28097345 |
35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.22063209 |
36 | Peroxisome_Homo sapiens_hsa04146 | 1.18931869 |
37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18747319 |
38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.16209427 |
39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.15553410 |
40 | Spliceosome_Homo sapiens_hsa03040 | 1.14969206 |
41 | Huntingtons disease_Homo sapiens_hsa05016 | 1.10252469 |
42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09308239 |
43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.09033896 |
44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09000219 |
45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.08872241 |
46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08733907 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08630074 |
48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.08583684 |
49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.08315523 |
50 | Purine metabolism_Homo sapiens_hsa00230 | 1.07908383 |
51 | Base excision repair_Homo sapiens_hsa03410 | 1.07861438 |
52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.06140003 |
53 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.03860644 |
54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01952003 |
55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00122901 |
56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.99946884 |
57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99050137 |
58 | Homologous recombination_Homo sapiens_hsa03440 | 0.97370262 |
59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95918455 |
60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94995545 |
61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94826350 |
62 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.91934929 |
63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91522738 |
64 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.90785290 |
65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90535075 |
66 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.89918657 |
67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89301040 |
68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88693950 |
69 | Pertussis_Homo sapiens_hsa05133 | 0.88404372 |
70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.87399039 |
71 | Mineral absorption_Homo sapiens_hsa04978 | 0.86260779 |
72 | Phagosome_Homo sapiens_hsa04145 | 0.86125597 |
73 | Mismatch repair_Homo sapiens_hsa03430 | 0.84518069 |
74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84071645 |
75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83569829 |
76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82979705 |
77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.79742156 |
78 | Tuberculosis_Homo sapiens_hsa05152 | 0.78843958 |
79 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77258316 |
80 | Lysosome_Homo sapiens_hsa04142 | 0.76497055 |
81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76241057 |
82 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75625187 |
83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74581661 |
84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73204236 |
85 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72056822 |
86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70882812 |
87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69540367 |
88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68441431 |
89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68112589 |
90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68010841 |
91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66080848 |
92 | Hepatitis C_Homo sapiens_hsa05160 | 0.65933925 |
93 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65122086 |
94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.63630901 |
95 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63595401 |
96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63319579 |
97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62976429 |
98 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62123715 |
99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61689976 |
100 | Measles_Homo sapiens_hsa05162 | 0.61248557 |
101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60853202 |
102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59323841 |
103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58220002 |
104 | Allograft rejection_Homo sapiens_hsa05330 | 0.57882331 |
105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57453344 |
106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55084773 |
107 | Hepatitis B_Homo sapiens_hsa05161 | 0.53915470 |
108 | Influenza A_Homo sapiens_hsa05164 | 0.53102804 |
109 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52424162 |
110 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50918735 |
111 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.50905909 |
112 | RNA transport_Homo sapiens_hsa03013 | 0.50674303 |
113 | Malaria_Homo sapiens_hsa05144 | 0.50543513 |
114 | Apoptosis_Homo sapiens_hsa04210 | 0.50408390 |
115 | Asthma_Homo sapiens_hsa05310 | 0.50205050 |
116 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.49551388 |
117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49036557 |
118 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.48460164 |
119 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.45800171 |
120 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.44797518 |
121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43575297 |
122 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.42456792 |
123 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.40577244 |
124 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.39712795 |
125 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39627937 |
126 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39080154 |
127 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.36822806 |
128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35889027 |
129 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.32387765 |
130 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.31977932 |
131 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.31721752 |
132 | Shigellosis_Homo sapiens_hsa05131 | 0.30314682 |
133 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.30170913 |